| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 468 | 246 | 294 | 489 | | Cost of Revenue | 197 | 158 | 78 | 130 | | | Gross Profit | 271 | 88 | 216 | 359 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 953 | 882 | 1,152 | 614 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 35 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (682) | (299) | (936) | (256) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (30) | (205) | 94 | 214 | | Earnings Before Interest And Taxes | (748) | (914) | (843) | (41) | | Interest Expense | 6 | (347) | 278 | 65 | | Income Before Tax | (754) | (567) | (1,121) | (106) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (754) | (567) | (1,121) | (106) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (754) | (567) | (1,121) | (106) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($754) | ($567) | ($1,121) | ($106) |
|
0.31% Nasdaq 
0.05%
Income Statement
